SOURCE: Novo Nordisk A/S

April 20, 2009 08:40 ET

Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - April 20, 2009) - Novo Nordisk A/S - Share repurchase programme


On 29 January 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

Since the announcement as of 6 April 2009, the following transactions have been made under the programme:


Number of Average Transaction shares purchase price value, DKK Accumulated, last announcement 3,832,041 1,081,993,735 6 April 2009 75,000 247.67 18,575,250 7 April 2009 76,700 251.47 19,287,749 8 April 2009 76,700 246.84 18,932,628 14 April 2009 81,700 238.14 19,456,038 15 April 2009 110,000 237.61 26,137,100 16 April 2009 77,000 243.53 18,751,425 17 April 2009 76,000 252.41 19,183,160 Accumulated under 4,405,141 1,222,317,085 the programme


With the transactions stated above, Novo Nordisk owns a total of 29,257,523 treasury shares, corresponding to 4.6% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Company Announcement no 22 / 2009


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.


Copyright © Hugin AS 2009. All rights reserved.

Contact Information

  • Further information:

    Media:

    Outside North America:
    Elin K Hansen
    Tel: (+45) 4442 3450
    Email Contact

    In North America:
    Sean Clements
    Tel: (+1) 609 514 8316
    Email Contact

    Investors:

    Outside North America:
    Mads Veggerby Lausten
    Tel: (+45) 4443 7919
    Email Contact

    Kasper Roseeuw Poulsen
    Tel: 4442 4471
    Email Contact

    In North America:
    Hans Rommer
    Tel: (+1) 609 919 7937
    Email Contact